Covid-19: Joint Statement from Unitaid and the World Health Organization
WHO and Unitaid are concerned by Roche’s statement on August 17, warning of a global shortage of tocilizumab (brand name Actemra/RoActemra), an IL6 inhibitor WHO recommended in June for use as a ...
